IMRN - Immuron Limited

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in AUD. All numbers in thousands
Breakdown
ttm
6/29/2019
6/29/2018
6/29/2017
6/29/2016
Total Revenue
-
2,387
1,843
1,396
1,001
Cost of Revenue
-
667
419
338
301
Gross Profit
-
1,720
1,424
1,059
700
Operating Expenses
Research Development
-
1,045
2,257
4,631
3,624
Selling General and Administrative
-
5,823
4,100
4,442
5,116
Total Operating Expenses
-
6,341
4,513
7,471
7,217
Operating Income or Loss
-
-4,621
-3,088
-6,413
-6,517
Interest Expense
-
0
19
24
342
Total Other Income/Expenses Net
-
-12
95
-375
-222
Income Before Tax
-
-4,633
-3,011
-6,804
-7,069
Income Tax Expense
-
0
0
0
0
Income from Continuing Operations
-
-4,633
-3,011
-6,804
-7,069
Net Income
-
-4,633
-3,011
-6,804
-7,069
Net Income available to common shareholders
-
-4,633
-3,011
-6,804
-7,069
Reported EPS
Basic
-
-
-0.92
-2.56
-3.70
Diluted
-
-
-0.92
-2.56
-3.70
Weighted average shares outstanding
Basic
-
-
3,342
2,647
1,911
Diluted
-
-
3,342
2,647
1,911
EBITDA
-
-4,627
-2,987
-6,775
-6,723